Trusted News Discovery Since 2008
{{/content}}
Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall
Credit: IndiaTimes- Published 2 weeks ago
UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped manufacturing Covishield in Dec 2021 due to a fall in demand as well as the emergence of new variants. Covishield accounted for nearly 80% of...
You are here
💡 newsR Knowledge: Other News Mentions
AstraZeneca
British pharmaceutical company
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..
Credit: IndiaTimes - Published 3 days ago
Oxford–AstraZeneca COVID-19 vaccine
Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
Serum Institute of India
Indian biotechnology and biopharmaceuticals company
Related videos from verified sources
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03
Credit: Oneindia - Published 3 weeks ago